Five minutes of junk food advertising ‘leads children to eat 130 extra calories'
A study found that advertising and marketing across platforms such as social media, TV and podcasts all had a similar effect.
The research, which has not yet been published in a peer-reviewed journal, was presented at the European Congress on Obesity in Malaga.
The study found that seven to 15-year-olds exposed to five minutes of adverts for foods high in saturated fat, sugar, and/or salt (HFSS) consumed on average 130 extra calories per day – the equivalent of a small chocolate bar.
Lead author, Professor Emma Boyland from the University of Liverpool, said: 'Even short exposure to marketing of foods high in fat, salt and sugar can drive excess calorie consumption and potentially weight gain, particularly in young people who are more susceptible to advertising and whose eating patterns influence their lifelong health.'
The research included 240 children aged seven to 15.
Analysis showed that following exposure to HFSS food ads, children consumed more snacks (an extra 58.4 calories), more lunch (an extra 72.5 calories), and more food overall (snack and lunch combined) than after exposure to non-food advertising.
Those children with a higher body mass index also showed a 'greater responsivity' to the food adverts, experts found.
The Government is introducing a ban on the targeting of junk food adverts at children from October this year.
It estimates this will prevent thousands of cases of childhood obesity.
The restrictions affect advertising for less healthy food or drink on television between 5.30am and 9pm, alongside paid-for advertising online at any time.
Other types of advertising, such as billboards and other outdoor advertising, are not be affected by the change.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Health Line
3 hours ago
- Health Line
Understanding Non-Mendelian Genetics (Patterns of Inheritance)
In Mendelian inheritance patterns, you receive one version of a gene, called an allele, from each parent. These alleles can be dominant or recessive. Non-Mendelian genetics don't completely follow these principles. Genetics is an expansive field that focuses on the study of genes. Scientists who specialize in genetics are called geneticists. Geneticists study many different topics, including: how genes are inherited from our parents how DNA and genes vary between different people and populations how genes interact with factors both inside and outside of the body If you're looking into more information on genetics topics, you may come across two types of genetics: Mendelian and non-Mendelian genetics. This article reviews both types of genetics, with a focus on non-Mendelian genetics. Continue reading to learn more. What is Mendelian genetics? It's possible that you may remember some concepts of Mendelian genetics from your high school biology class. If you've ever done a Punnett square, you've learned about Mendelian genetics. The principles of Mendelian genetics were established by the Austrian monk Gregor Mendel in the mid-19th century based on his experiments with pea plants. Through his experiments, Mendel pinpointed how certain traits (such as pea color) are passed down across generations. From this information, he developed the following three laws, which are the basis of Mendelian genetics: Dominance. Some variants of a gene, called alleles, are dominant over others. Non-dominant alleles are referred to as recessive. If both a dominant and recessive allele are inherited, the dominant trait will be the one that shows. Segregation. Offspring inherit one allele for a gene from each of their parents. These alleles are passed down randomly. Independent assortment. Genetic traits are inherited independently of each other. Pea color: An example of Mendelian genetics at work To illustrate how Mendelian genetics works, let's use an example with pea plants, in which yellow pea color (Y) is dominant and green pea color (y) is recessive. In this particular example, each parent pea plant is heterozygous, meaning it has a dominant and recessive allele, noted as Yy. When these two plants are bred, noted as Yy x Yy, the following pattern of inheritance will be seen: 25% of offspring will be homozygous dominant (YY) and have yellow peas. 50% of offspring will be heterozygous (Yy) and have yellow peas. 25% of offspring will be homozygous recessive (yy) and have green peas. What are examples of health conditions that follow Mendelian patterns of inheritance? There are several health conditions that follow Mendelian patterns of inheritance. Alleles for sickle cell anemia and cystic fibrosis are recessive. This means that you need two copies of the recessive allele, one from each parent, to have these conditions. In contrast, the allele for Huntington's disease is dominant. That means that you only need a single copy of the allele (from one of your parents) to have it. Sex-linked conditions Some health conditions can be linked to genes in the sex chromosomes (X and Y). For example, hemophilia is X-linked recessive. In those assigned male at birth, who have a single X chromosome, only one copy of the recessive allele is enough to have hemophilia. That's why hemophilia is more common in males. Individuals assigned female at birth have two X chromosomes, meaning they need two copies of the recessive allele to have hemophilia. What are non-Mendelian genetics? Exceptions exist for every rule, and that's also true for genetics. Simply put, non-Mendelian genetics refers to inheritance patterns that don't follow Mendel's laws. Here are some different types of non-Mendelian genetics: Polygenic traits Some traits are determined by two or more genes instead of just one. These are called polygenic traits and don't follow Mendelian inheritance patterns. Examples of polygenic health conditions include: hypertension diabetes certain cancers, such as breast and prostate cancer Mitochondrial inheritance Your mitochondria are the energy factories of your cells and also contain their own DNA, called mtDNA. While there are some exceptions, mtDNA is usually inherited from your mother. You get your mtDNA from your mother because the mitochondria present in sperm typically degrade after fertilization. This leaves behind just the mitochondria in the egg. Examples of Mitochondrial health conditions include Leber hereditary optic neuropathy (LHON) and mitochondrial encephalomyopathy. Epigenetic inheritance Epigenetics refers to how genes are expressed and regulated by factors outside of the DNA sequence. This includes things like DNA methylation, in which a chemical called a methyl group is added to a gene, turning it 'on' or 'off'. Epigenetic factors can change as we get older and are exposed to different things in our environment. Sometimes, these changes can be passed down to the next generation, which is called epigenetic inheritance. Certain cancers (such as breast, colorectal, and esophageal cancer) have been linked to epigenetic changes. Neurological disorders like Alzheimer's and metabolic diseases like Type 2 diabetes have also been associated with epigenetic inheritance. Genetic imprinting While we inherit two copies of a gene, one from each parent, in some cases, only one copy of the gene may be turned 'on' via DNA methylation. This is called imprinting, and it only affects a small percentage of our genes. Which gene is turned 'on' can depend on where the gene came from. For example, some genes are only turned 'on' when they come from the egg, while others are only 'on' when they come from the sperm. Examples of conditions associated with genetic imprinting include Beckwith-Wiedemann syndrome, Silver-Russell syndrome, and Transient Neonatal Diabetes Mellitus. Gene conversion Gene conversion can happen during meiosis, the type of cell division that helps make sperm and eggs. After meiosis, each sperm and egg contains one set of chromosomes and therefore one set of alleles to be passed down to offspring. During meiosis, genetic information from one copy of an allele (the donor) may be transferred to the corresponding allele (the recipient). This results in a genetic change that effectively converts the recipient allele to the donor allele. Genetic conditions influenced by gene conversions include hemophilia A, sickle cell disease, and congenital adrenal hyperplasia. What are examples of health conditions that follow non-Mendelian patterns of inheritance? Most health conditions we're familiar with don't follow Mendelian inheritance patterns. These conditions are often polygenic, meaning the effects of multiple genes contribute to them. For example, cystic fibrosis is caused by inheriting two copies of a recessive allele of a specific gene. However, there's not an isolated 'heart disease' allele that we inherit that causes us to develop heart disease. Mitochondrial disorders, which are caused by changes in mtDNA, are another type of health condition that follows non-Mendelian patterns of inheritance. This is because you typically inherit mtDNA from your mother. Sometimes problems with genetic imprinting can lead to disorders. Prader-Willi syndrome and Beckwith-Wiedemann syndrome are two examples. How do Mendelian and non-Mendelian genetics contribute to our understanding of genetic diseases in humans? Understanding both Mendelian and non-Mendelian inheritance patterns is important in understanding how different genetic diseases may be passed down. For example, if you have a certain genetic disease or you know that one runs in your family, you may have concerns about future children inheriting it. In this situation, working with a medical professional, such as a genetic counselor, who understands a disease's inheritance patterns can help you get an understanding of the risk of future children having the disease. Additionally, understanding genetic changes and inheritance can affect future therapies. This information can be important for developing gene therapies for a variety of genetic diseases. Takeaway Mendelian genetics focuses on the principles that there are dominant and recessive alleles and that we randomly inherit one copy of an allele from each parent. Some health conditions follow basic Mendelian inheritance patterns. Examples include cystic fibrosis and Huntington's disease. Non-Mendelian genetics don't follow the principles outlined by Mendel. Many health conditions we're familiar with don't follow Mendelian inheritance patterns because they're polygenic, affect mtDNA, or are associated with imprinting.
Medscape
3 hours ago
- Medscape
When Medicine Meets Philosophy: A New SEC Series
Medicine and Philosophy, a new roundtable series by the Spanish Society of Cardiology (SEC) in collaboration with Madrid's Círculo de Bellas Artes, aims to facilitate discussions between medical, science, and humanities experts. The series, which took place in May and June, was recorded and can be viewed online at the SEC's channel. Organizers and Topics The Hippocratic Chapter of the SEC, along with organizers from the Círculo de Bella Artes, decided on three healthcare topics to explore in the series. The session titles were "The Doctor-Patient Relationship in the Era of Artificial Intelligence," "Who Wants to Live Forever?", and "Is Boredom a Medical Problem? AI in Medicine: Pros and Cons AI's role in medicine was the first session's focus. Panelists discussed how AI saves time by streamlining data interpretation, allowing more time spent with patients. Ironically, the extra time results in the expectation that patient load should increase. The importance of physician input in AI advancement for medical use, as well as educating future clinicians on AI, were discussed. A Long Life The concept of living a longer life was discussed in the second session. A balanced approach to the topic by medical professionals and philosophers created a crossover of biological facts with existential questions about the meaning of life. Is Boredom Treatable? The last session featured panelists talking about boredom, whether it is a medical issue, and the social and medical repercussions of labeling these normal emotional life experiences as treatable conditions. Were These Roundtables Successful? Yes. All sessions sold out and this success has prompted the organizers to brainstorm future topics for collaboration. Also, expanding this series outside of Madrid is a possibility. Bottom line: Viewing healthcare topics through scientific and philosophical lenses can foster thought-provoking discussions, as shown by the success of the Medicine and Philosophy roundtable series. The full list of panelists can be found on the Círculo de Bellas Artes page for the roundtable series.
Yahoo
4 hours ago
- Yahoo
Novo Nordisk shares dip further as Wegovy gains nearly erased
By Jacob Gronholt-Pedersen (Reuters) -Shares in Novo Nordisk fell as much as 6% on Friday before recovering some ground later in the session, extending recent losses that threaten to wipe out all the gains since the drugmaker launched its blockbuster weight-loss treatment Wegovy four years ago. The fall on Friday means the Danish firm has dropped out of the top 10 constituents of the Europe-wide STOXX 600 index. Share price declines across the sector were prompted by U.S. President Donald Trump, who sent letters on Thursday to 17 major pharmaceutical firms, including Novo Nordisk, telling them to cut drug prices in the United States. Novo Nordisk on Tuesday slashed its forecast for 2025 sales growth due to competition from compounded, or copycat, versions of Wegovy and appointed veteran insider Maziar Mike Doustdar as its new CEO, prompting its shares to fall 23% on the day. Novo became Europe's most valuable listed firm after launching Wegovy in June 2021, worth some $650 billion in the middle of last year. But its shares have lost more than two-thirds since on concerns the drugmaker is losing ground in the obesity drug race. Its market cap is now $214.5 billion. "The U.S. healthcare system is complex, but Novo Nordisk will continue to work to find solutions that help people access the medicines they need at affordable prices," Novo said in an emailed statement. Novo's shares were around 2% lower at 1453 GMT, bringing this week's losses to around 30% - the stock's worst week ever. The European healthcare index was down around 1% to its lowest since April. "Trump doesn't have the mandate to tell Novo Nordisk how to price their products in the U.S., but investors are just panicking about the risk of another downgrade," said Nordnet analyst Per Hansen. The pressure to lower prices adds to Novo's problems in the United States, its biggest market. It faces competition from Eli Lilly and from compounders - custom-made medicines that are based on the same ingredients as branded drugs. "This is a repricing of the obesity market, it's a repricing of the United States as the world's most attractive drug market, and it's a repricing of the risk from Donald Trump," Hansen said. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
